Ginkgo Bioworks
DNA
DNA
173 hedge funds and large institutions have $197M invested in Ginkgo Bioworks in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 179 → 173 (-6)
27% less capital invested
Capital invested by funds: $270M → $197M (-$73.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
173
Holding in Top 10
2
Calls
$1.79M
Puts
$1.59M
Top Buyers
| 1 | +$3.65M | |
| 2 | +$2.25M | |
| 3 | +$2.09M | |
| 4 |
N
Numerai
San Francisco,
California
|
+$1.25M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.03M |
Top Sellers
| 1 | -$2.55M | |
| 2 | -$2.08M | |
| 3 | -$1.88M | |
| 4 |
Jane Street
New York
|
-$1.51M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$1.24M |
